Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis
Diagnostics · 04.01.2023 · 13 (2) · 185
DOI: 10.3390/diagnostics13020185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 04.01.2023. Verfasst von Mahmoud Rezk Abdelwahed Hussein und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Assiut University Hospitals, Asyut 2074020, Egypt. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dermatofibromas (DFs) are benign fibrohistiocytic lesions that usually do not express CD34 protein. This study aimed to analyze the literature concerning the immunohistological and ultrastructural features of DFs. It also related these features to the histogenesis of these lesions.
Methods
This study included a PubMed literature search for studies addressing the clinicopathological, ultrastructural, and immunohistochemical features of DFs. It also presented some current cases of CD34-negative DFs and a subset of these lesions with aberrant expression of this protein.
Results
Analysis of the PubMed literature revealed that DFs with an aberrant expression of CD34 are rare tumors that commonly affect the extremities of adult females. Separating these tumors from dermatofibrosarcoma protuberans (DFSP, CD34-positive tumors) requires using a large panel of immunostains. Ultrastructurally, DFs are composed of diverse cell types, including cells with histiocytic, myofibroblastic, and fibroblastic features. An analysis of the DFs described by this study revealed that cases with an aberrant expression of CD34 protein had slightly high mean age and male sex predominance when compared to CD34-negative cases. The former commonly affected the extremities. There was no evidence of local recurrence or distant metastasis on follow-up.
Conclusions
DFs have the potential to express CD34 protein, defining a rare aberrant phenotype, which was not associated with any differences in the outcome as compared to CD34-negative DFs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Assiut University Hospitals, Asyut 2074020, Egypt.
- Faculty of Medicine, Sohag University, Sohag 1646130, Egypt.
ORCID-Profile: Mahmoud Rezk Abdelwahed Hussein
Zitieren
APA
Hussein, M. R. A., & Abdelwahed Hussein, T. M. R. (2023). Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis. Diagnostics, 13(2), 185. https://doi.org/10.3390/diagnostics13020185
Vancouver
Hussein MRA, Abdelwahed Hussein TMR. Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis. Diagnostics. 2023;13(2):185. doi:10.3390/diagnostics13020185
BibTeX
@article{Hussein2023,
author = {Hussein, Mahmoud Rezk Abdelwahed and Abdelwahed Hussein, Toka Mahmoud Rezk},
title = {Dermatofibromas with Aberrant Expression of CD34 Protein: A Systematic Review and a Reappraisal of Clinicopathological Features and Histogenesis},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {2},
pages = {185},
doi = {10.3390/diagnostics13020185}
}
EUVIMED